27 December 2023
Sidley Represents Biolojic Design in Exclusive License Agreement with Teva for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Asher Rubin Lead | Sidley | Partner | Technology and Life Sciences Transactions | Not stated |
| Eden Moalem Lead | Sidley | Partner | Emerging Companies and Venture Capital | Not stated |
| Yahel Kaplan | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Cassidy A. Pomeroy-Carter | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Biolojic Design Ltd.Other
- Counterparties
- Teva Pharmaceutical Industries Ltd. (Other)